Hansen Gwenn bought NRIX

January 30, 2026 · Form 4 insider transaction

Hansen Gwenn bought 3,750 shares of Nurix Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.